Chronic conditions drive key drug spend classes
Serving large populations costly medicines is complex. Get the breakdown of the top spending categories — including drug costs and competition — and strategies to combat them.
Related content
Weighty issue: How to contain GLP-1 costs
Managing diabetes gains an 8:1 return on investment